According to Silence Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 33.8114. At the end of 2023 the company had a P/S ratio of 21.2.
Year | P/S ratio | Change |
---|---|---|
2023 | 21.2 | -16.74% |
2022 | 25.5 | -32.88% |
2021 | 38.0 |